Detailed Mechanism Funding and Narrative

Years of mechanism: 2015 2016 2017 2018

Details for Mechanism ID: 17862
Country/Region: Botswana
Year: 2016
Main Partner: FHI 360
Main Partner Program: NA
Organizational Type: NGO
Funding Agency: USAID
Total Funding: $900,000 Additional Pipeline Funding: $674,437

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Strategic Information (HVSI) $500,000
Sexual Prevention: Other Sexual Prevention (HVOP) $171,012
Treatment: Adult Treatment (HTXS) $228,988
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2017 2,265
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2017 531
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2017 2,796
HTS_TST Service Delivery Point (Community): Homebased testing 2017 230
HTS_TST Service Delivery Point (Community): Mobile testing 2017 855
HTS_TST Service Delivery Point (Facility): Other PITC 2017 259
HTS_TST Service Delivery Point (Facility): VCT 2017 1,452
HTS_TST Sum of Aggregated Age/Sex 15+ 2017 2,796
HTS_TST Sum of Aggregated Age/Sex disaggregates 2017 2,796
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Female 2017 558
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Male 2017 132
KP_PREV By key population type: Female sex workers (FSW) (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) 2017 3,313
KP_PREV By key population type: Men who have sex with men who are NOT sex workers (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) 2017 722
KP_PREV Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required 2017 4,035
KP_PREV Total estimated number of key population in the catchment area 2017 5,763
KP_PREV_den By key population type: Female sex workers (FSW) (Denominator: Total estimated number of key population in the catchment area) 2017 4,731
KP_PREV_den By key population type: Men who have sex with men who are NOT sex workers (Denominator: Total estimated number of key population in the catchment area) 2017 1,032
TB_SCREENDX [Sub-Disagg of Specimen Sent] Diagnostic Test: Xpert MTB/RIF assay 2017 564
TB_SCREENDX Screened for TB by Age/Sex: 15+ Female 2017 564
TB_SCREENDX The number of PLHIV who were screened for TB symptoms at the last clinical visit at a HIV facility during the reporting period 2017 564
TX_CURR Aggregated Age/Sex: 15+ Female 2017 814
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2017 814
TX_CURR Sum of Aggregated Age/Sex 15+ 2017 814
TX_CURR Sum of Aggregated Age/Sex disaggregates 2017 814
TX_NEW Aggregated Grouping by Age/Sex: 15+ Female 2017 305
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2017 305
TX_NEW Sum of Aggregated Age/Sex disaggregates 2017 305
TX_PVLS Number of adult and pediatric ART patients with a viral load result documented in the patient medical record and /or laboratory records in the past 12 months 2017 643
TX_PVLS Number of adults and pediatric patients on ART with suppressed viral load results (<1,000 copies/ml) documented in the medical records and /or supporting laboratory results within the past 12 months 2017 610
TX_PVLS Numerator Aggregated Age/Sex: 15+ Female 2017 610
TX_PVLS Numerator: Indication: Routine 2017 610
TX_PVLS_den Denominator Aggregated Age/Sex: 15+ Female 2017 643
TX_PVLS_den Denominator: Indication: Routine 2017 643
TX_RET Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 372
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2017 372
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2017 465
TX_RET_den Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 465
Cross Cutting Budget Categories and Known Amounts Total: $790,167
Gender: Gender Equality $600,566
Equity in HIV prevention, care, treatment and support
Gender: Gender Based Violence (GBV) $189,601
GBV Prevention